Thursday, January 10, 2008

Behavioral Health Viewpoint - Drug Patent Protection

Behavioral Wellness Position - Drug Papers Indorsement


from Drug Goodness Trends

Electric potential Benefits to Consumer


In the case of Prozac, the marginal cost of producing an additional unit of the newer (single isomer) writing of the drug should be minimal, since a large firm like Lilly has extensive knowledge about fitness the brand-name drug.
Furthermore, the pharmaceutical unit is not starting from the start to develop this drug.
An experienced pharmaceutical enquiry band would payment from cost-reducing “learning-by-doing” effects acquired through class of R&D programs.
If, as the companies hope, there actually are fewer side effects for the ace isomer edition of fluoxetine, then mercantilism the “new, improved” Prozac should be straightforward.
This is a part of article Behavioral Health Viewpoint - Drug Patent Protection Taken from "Cheap Prozac Fluoxetine" Information Blog

No comments: